✦ LIBER ✦

A phase I study of weekly oxaliplatin (OXA) + continous infusion (CI) fluorouracil (FU) in patients with advanced colorectal cancer(CCR)

✍ Scribed by A. Aschele; S. Lonardi; L. Sartor; A. Perin; V. Chiarion Sileni; G. Artioli; S. Monfardini

Book ID: 117658127
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 192 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80757-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of weekly oxaliplatin (O

A phase I study of weekly oxaliplatin (OXA), 5-fluorouracil (5-FU) continuous infusion and preoperative radiotherapy in locally advanced rectal cancer

✍ C. Aschele; M. Friso; S. Pucciarelli; G. Babris; B. Martella; G. Da Dalt; E. Urs 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Phase III trial of bolus 5-fluorouracil

Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)

✍ A. Grothey; T. Buechele; H. Kroening; K. Ridwelski; P. Reichardt; A. Kretzschmar 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase II study of leucovorin (LV)-modu

A phase II study of leucovorin (LV)-modulated continuous infusion (CI) fluorouracil (DU) + CPT-11 alternating with LV-modulated CI FU + Oxaliplatin (L-OHP) in advanced colorectal cancer (CCR): high activity and low toxicity

✍ Aschele, A.; Lonardi, S.; Sartor, L.; Perin, A.; Koussis, B.; Nicoletto, O.; Mon 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 194 KB

An EORTC phase I study of Bortezomib in

An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer

✍ F. Caponigro; D. Lacombe; C. Twelves; J. Bauer; A.-S. Govaerts; S. Marréaud; A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 214 KB

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

A phase II study of irinotecan plus chro

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

✍ Garufi, C; Bria, E; Vanni, B; Zappalà, A M R; Sperduti, I; Terzoli, E 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB